Anti-hypertensive medications and erectile dysfunction: focus on β-blockers.
Antihypertensive medications
Beta-blockers
Erectile dysfunction
Hypertension
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
13 Sep 2024
13 Sep 2024
Historique:
received:
30
03
2024
accepted:
23
08
2024
medline:
13
9
2024
pubmed:
13
9
2024
entrez:
13
9
2024
Statut:
aheadofprint
Résumé
Although anti-hypertensive medications, including thiazides and β-blockers (BBs) in particular, have been suggested to cause erectile dysfunction (ED) their real contribution is still conflicting. The aim of this paper is to summarize available evidence providing an evidence-based critical analysis of the topic. An overall comprehensive narrative review was performed using Medline, Embase and Cochrane search. In addition, to better understand the impact of BBs on ED a specific systematic review was also performed. The negative role of centrally acting drugs, such as clonidine and α-methyldopa, is well documented althuogh limited controlled trials are available. Angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor blockers (ARBs), and calcium-channel-blockers (CCBs) have neutral (CCBs) or even positive (ACEis and ARBs) effects on erectile function. Despite some preliminary negative reports, more recent evidence does not confirm the negative impact of thiazides. BBs should be still considered the class of medications more often associated with ED, although better outcomes can be drawn with nebivolol. Sexual function should be assessed in all patients with arterial hypertension, either at diagnosis or after the prescription of specific medications. A close related patient-physician interaction and discussion can overcome possible negative outcomes allowing a successful management of possible side effects.
Identifiants
pubmed: 39269577
doi: 10.1007/s12020-024-04020-x
pii: 10.1007/s12020-024-04020-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society
ID : AGE-IT -CUP B83C22004800006
Organisme : Recovery and Resilience Plan, Investment PE8 - Project Age-It: "Ageing Well in an Ageing Society
ID : AGE-IT -CUP B83C22004800006
Informations de copyright
© 2024. The Author(s).
Références
NCD Risk Factor Collaboration (NCD-RisC), Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 389(Jan 10064), 37–55 (2017)
B. Williams, G. Mancia, W. Spiering et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press 27(Dec 6), 314–340 (2018)
pubmed: 30380928
doi: 10.1080/08037051.2018.1527177
G. Corona, M. Monami, V. Boddi et al. Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. J Sex Med 8(Jan 1), 247–254 (2011)
pubmed: 20722787
doi: 10.1111/j.1743-6109.2010.01966.x
M. Brunström, B. Carlberg, Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med 178(Jan 1), 28–36 (2018)
pubmed: 29131895
doi: 10.1001/jamainternmed.2017.6015
I.T. Farmakis, N. Pyrgidis, I. Doundoulakis et al. Effects of major antihypertensive drug classes on erectile function: a network meta-analysis. Cardiovasc Drugs Ther 36(Oct 5), 903–914 (2022)
pubmed: 33945044
doi: 10.1007/s10557-021-07197-9
G. Corona, D. Cucinotta, G. Di Lorenzo et al. The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction. J Endocrinol Invest 46(Jun 6), 1241–1274 (2023)
pubmed: 36698034
pmcid: 9876440
doi: 10.1007/s40618-023-02015-5
R.H. Grimm Jr, G.A. Grandits, R.J. Prineas et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 29(Jan 1 Pt 1), 8–14 (1997)
pubmed: 9039073
doi: 10.1161/01.HYP.29.1.8
C.B. Johannes, A.B. Araujo, H.A. Feldman et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 163(Feb 2), 460–463 (2000)
pubmed: 10647654
G. Corona, D.M. Lee, G. Forti et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med 7(Apr 4 Pt 1), 1362–1380 (2010)
pubmed: 19929914
doi: 10.1111/j.1743-6109.2009.01601.x
A. Ponholzer, C. Temml, K. Mock et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 47(Jan 1), 80–85 (2005).
pubmed: 15582253
doi: 10.1016/j.eururo.2004.08.017
G. Corona, E. Mannucci, F. Lotti et al. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6(Jan 1), 285–293 (2009)
pubmed: 19170856
doi: 10.1111/j.1743-6109.2008.01059.x
D.G. Corona, W. Vena, A. Pizzocaro et al. Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study. J Endocrinol Invest 46(Nov 11), 2195–2211 (2023)
pubmed: 37515706
doi: 10.1007/s40618-023-02136-x
M. Viigimaa, C. Vlachopoulos, M. Doumas et al. Update of the position paper on arterial hypertension and erectile dysfunction. J Hypertens 38(Jul 7), 1220–1234 (2020)
pubmed: 32073535
doi: 10.1097/HJH.0000000000002382
A. Salonia, C. Bettocchi, L. Boeri et al. European Association of Urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol 80(Sep 3), 333–357 (2021)
pubmed: 34183196
doi: 10.1016/j.eururo.2021.06.007
M. Gacci, V. Ficarra, A. Sebastianelli et al. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. J Sex Med 11(Jun 6), 1554–1566 (2014)
pubmed: 24708055
doi: 10.1111/jsm.12525
R.C. Rosen, J.B. Kostis, A.W. Jekelis, Beta-blocker effects on sexual function in normal males. Arch Sex Behav 17(Jun 3), 241–255 (1988)
pubmed: 2900627
doi: 10.1007/BF01541742
R.C. Rosen, J.B. Kostis, A. Jekelis et al. Sexual sequelae of antihypertensive drugs: treatment effects on self-report and physiological measures in middle-aged male hypertensives. Arch Sex Behav 23(Apr 2), 135–152 (1994)
pubmed: 8018020
doi: 10.1007/BF01542095
A. Cordero, V. Bertomeu-Martínez, P. Mazón et al. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther 28(1), 15–22 (2010)
pubmed: 20074255
doi: 10.1111/j.1755-5922.2009.00123.x
A. Silvestri, P. Galetta, E. Cerquetani et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 24(Nov 21), 1928–1932 (2003)
pubmed: 14585251
doi: 10.1016/j.ehj.2003.08.016
K. Brixius, M. Middeke, A. Lichtenthal et al. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 34(Apr 4), 327–331 (2007)
pubmed: 17324145
doi: 10.1111/j.1440-1681.2007.04551.x
Ö. Gür, S. Gurkan, G. Yumun et al. The comparison of the effects of nebivolol and metoprolol on erectile dysfunction in the cases with coronary artery bypass surgery. Ann Thorac Cardiovasc Surg 23(Apr 2), 91–95 (2017)
pubmed: 28302931
pmcid: 5422634
doi: 10.5761/atcs.oa.16-00242
G. Corona, V. Ricca, E. Bandini et al. Association between psychiatric symptoms and erectile dysfunction. J Sex Med 5(Feb 2), 458–468 (2008)
pubmed: 18004996
doi: 10.1111/j.1743-6109.2007.00663.x
G. Corona, E. Mannucci, L. Petrone et al. Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. J Androl 27(May-Jun 3), 453–458 (2006)
pubmed: 16339452
doi: 10.2164/jandrol.05154
G. Corona, S. Bianchini, A. Sforza et al. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones 14(Oct-Dec 4), 569–578 (2015)
pubmed: 26732155
E. Maseroli, G. Corona, G. Rastrelli et al. Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. J Sex Med 12(Apr 4), 956–965 (2015)
pubmed: 25689116
doi: 10.1111/jsm.12832
G. Corona, E. Mannucci, G. Forti et al. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl 32(Oct 5), 431–441 (2009)
pubmed: 19538523
doi: 10.1111/j.1365-2605.2009.00965.x
H. Mostafaei, K. Mori, S. Hajebrahimi et al. Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses. BJU Int 128(Jul 1), 3–11 (2021)
pubmed: 33260254
pmcid: 8359379
doi: 10.1111/bju.15313
S. Seidu, A. Cebrián, S.K. Kunutsor et al. Erectile dysfunction, phosphodiesterase-5 inhibitor use and risk of cardiovascular disease and mortality in people with diabetes: a systematic review and meta-analysis. Prim Care Diabetes 16(Oct 5), 601–613 (2022)
pubmed: 36114105
doi: 10.1016/j.pcd.2022.09.004
S. Crown, A.H. Crisp, A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 112(Sep 490), 917–923 (1966)
pubmed: 5970912
doi: 10.1192/bjp.112.490.917
M. Karavitakis, C. Komninos, P.N. Theodorakis et al. Evaluation of sexual function in hypertensive men receiving treatment: a review of current guidelines recommendation. J Sex Med 8(Sep 9), 2405–2414 (2011)
pubmed: 21676187
doi: 10.1111/j.1743-6109.2011.02342.x
G. Mancia, G. De Backer, A. Dominiczak et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(Jun 6), 1105–1187 (2007)
pubmed: 17563527
doi: 10.1097/HJH.0b013e3281fc975a
H.B. Moss, W.R. Procci, Sexual dysfunction associated with oral antihypertensive medication: a critical survey of the literature. Gen Hosp Psychiatry 4(Jul 2), 121–129 (1982)
pubmed: 7117827
doi: 10.1016/0163-8343(82)90041-X
M.C. Laver, Sexual behaviour patterns in male hypertensives. Aust N Z J Med 4(Feb 1), 29–31 (1974)
pubmed: 4526512
doi: 10.1111/j.1445-5994.1974.tb03142.x
W.D. Alexander, J.I. Evans, Letter: side effects of methyldopa. Br Med J 2(May 5969), 501 (1975)
pubmed: 1148679
pmcid: 1673419
doi: 10.1136/bmj.2.5969.501-a
B. Srilatha, P.G. Adaikan, S. Arulkumaran et al. Sexual dysfunction related to antihypertensive agents: results from the animal model. Int J Impot Res 11(Apr 2), 107–113 (1999)
pubmed: 10356671
doi: 10.1038/sj.ijir.3900393
R. Shiri, J. Koskimäki, J. Häkkinen et al. Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res 19(Mar-Apr 2), 208–212 (2007)
pubmed: 16900205
doi: 10.1038/sj.ijir.3901516
M. Doumas, A. Tsakiris, S. Douma et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl 8(Mar 2), 177–182 (2006)
pubmed: 16491268
doi: 10.1111/j.1745-7262.2006.00076.x
M. Baumhäkel, N. Schlimmer, M. Kratz et al. Cardiovascular risk, drugs and erectile function-a systematic analysis. Int J Clin Pract 65(Mar 3), 289–298 (2011)
pubmed: 21314866
doi: 10.1111/j.1742-1241.2010.02563.x
C.A. Derby, M.M. Barbour, A.L. Hume et al. Drug therapy and prevalence of erectile dysfunction in the Massachusetts male aging study cohort. Pharmacotherapy 21(Jun 6), 676–683 (2001)
pubmed: 11401181
doi: 10.1592/phco.21.7.676.34571
H.G. Langford, R.W. Rockhold, S. Wassertheil-Smoller et al. Effect of weight loss on thiazide produced erectile problems in men. Trans Am Clin Climatol Assoc 101, 190–194 (1990)
pubmed: 2486442
pmcid: 2376483
J.E. Marley, Safety and efficacy of nifedipine 20 mg tablets in hypertension using electronic data collection in general practice. J R Soc Med 82(May 5), 272–275 (1989)
pubmed: 2754681
pmcid: 1292130
doi: 10.1177/014107688908200509
P.A. Poole-Wilson, B.A. Kirwan, Z. Vokó et al. Safety of nifedipine GITS in stable angina: the ACTION trial. Cardiovasc Drugs Ther 20(Feb 1), 45–54 (2006)
pubmed: 16552473
doi: 10.1007/s10557-006-6312-4
M. Fovaeus, K.E. Andersson, H. Hedlund, Effects of some calcium channel blockers on isolated human penile erectile tissues. J Urol 138(Nov 5), 1267–1272 (1987)
pubmed: 3669187
doi: 10.1016/S0022-5347(17)43582-8
M. Ushiyama, T. Kuramochi, S. Katayama, Treatment with hypotensive agents affects the impaired relaxation of the penile corpus cavernosum in hypertensive rats. Hypertens Res 29(Jul 7), 523–532 (2006)
pubmed: 17044665
doi: 10.1291/hypres.29.523
I. Mykoniatis, N. Pyrgidis, I. Sokolakis et al. Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis. JAMA Netw Open 4(Feb 2), e2036337 (2021)
pubmed: 33599772
pmcid: 7893498
doi: 10.1001/jamanetworkopen.2020.36337
M. Gacci, G. Corona, M. Salvi et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 61(May 5), 994–1003 (2012)
pubmed: 22405510
doi: 10.1016/j.eururo.2012.02.033
T.G. Speel, L.A. Kiemeney, T. Thien et al. Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study. J Sex Med 2(Mar 2), 207–212 (2005)
pubmed: 16422888
doi: 10.1111/j.1743-6109.2005.20230.x
I. Kifor, G.H. Williams, M.A. Vickers et al. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 157(May 5), 1920–1925 (1997)
pubmed: 9112563
doi: 10.1016/S0022-5347(01)64901-2
K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74(Jun 6), 1141–1148 (1994)
pubmed: 8187280
doi: 10.1161/01.RES.74.6.1141
S.B. Ismail, N.M. Noor, N.H.N. Hussain et al. Angiotensin receptor blockers for erectile dysfunction in hypertensive men: a brief meta-analysis of randomized control trials. Am J Mens Health 13(Nov-Dec 6), 1557988319892735 (2019)
pubmed: 31795911
pmcid: 6893938
R.G. Taylor, A.J. Crisp, B.I. Hoffbrand et al. Plasma sex hormone concentrations in men with hypertension treated with methyldopa and/or propranolol. Postgrad Med J 57(Jul 669), 425–426 (1981)
pubmed: 6796950
pmcid: 2424978
doi: 10.1136/pgmj.57.669.425
J. Jensen, A. Lendorf, H. Stimpel et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 12(Mar 3), 271–275 (1999)
pubmed: 10192229
doi: 10.1016/S0895-7061(98)00225-8
M. Burchardt, T. Burchardt, L. Baer et al. Hypertension is associated with severe erectile dysfunction. J Urol 164(Oct 4), 1188–1191 (2000)
pubmed: 10992363
doi: 10.1016/S0022-5347(05)67138-8
W.A. Blumentals, R.R. Brown, A. Gomez-Caminero, Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Int J Impot Res 15(Oct 5), 314–317 (2003)
pubmed: 14562130
doi: 10.1038/sj.ijir.3901041
W.A. Blumentals, A. Gomez-Caminero, S. Joo et al. Is erectile dysfunction predictive of peripheral vascular disease? Aging Male 6(Dec 4), 217–221 (2003)
pubmed: 15006259
doi: 10.1080/13685530312331309752
P.K. Moulik, K.J. Hardy, Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 20(Apr 4), 290–293 (2003)
pubmed: 12675642
doi: 10.1046/j.1464-5491.2003.00911.x
A. Roth, O. Kalter-Leibovici, Y. Kerbis et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. Clin Cardiol 26(Jan 1), 25–30 (2003)
pubmed: 12539809
doi: 10.1002/clc.4960260106
P. Montorsi, P.M. Ravagnani, S. Galli et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 27(Nov 22), 2632–2639 (2006)
pubmed: 16854949
doi: 10.1093/eurheartj/ehl142
M. Böhm, M. Baumhäkel, J.L. Probstfield et al. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ongoing telmisartan alone and in combination with Ramipril Global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND). Am Heart J 154(Jul 1), 94–101 (2007)
pubmed: 17584560
doi: 10.1016/j.ahj.2007.03.024
J. Falkensammer, A.G. Hakaim, C.E. Falkensammer et al. Prevalence of erectile dysfunction in vascular surgery patients. Vasc Med 12(Feb 1), 17–22 (2007)
pubmed: 17451089
doi: 10.1177/1358863X06076043
J.M. Maroto-Montero, M.T. Portuondo-Maseda, M. Lozano-Suárez et al. Erectile dysfunction in patients in a cardiac rehabilitation program. Rev Esp Cardiol 61(Sep 9), 917–922 (2008)
pubmed: 18775232
doi: 10.1157/13125512
N. Artom, G. Pinna, N.R. Musso et al. Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects. Clin Exp Hypertens 38(2), 143–149 (2016)
pubmed: 26418513
doi: 10.3109/10641963.2015.1060994
B. Nisahan, T. Kumanan, N. Rajeshkannan et al. Erectile dysfunction and associated factors among men with diabetes mellitus from a tertiary diabetic center in Northern Sri Lanka. BMC Res Notes 12(Apr 1), 210 (2019)
pubmed: 30953562
pmcid: 6451292
doi: 10.1186/s13104-019-4244-x
M.C. Correia, E.N. Ogola, J.K. Kayima et al. Erectile dysfunction in hypertensive males in Kenya: a tertiary referral hospital experience. Afr Health Sci 22(Jun 2), 420–427 (2022)
pubmed: 36407364
pmcid: 9652675
doi: 10.4314/ahs.v22i2.48
C. Zhao, J.L. Feng, S. Deng et al. Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study. Front Cardiovasc Med 10, 1157467 (2023)
pubmed: 37363097
pmcid: 10289031
doi: 10.3389/fcvm.2023.1157467
J.W. Hollifield, K. Sherman, R.V. Zwagg et al. Proposed mechanisms of propranolol’s antihypertensive effect in essential hypertension. N Engl J Med 295(Jul 2), 68–73 (1976)
pubmed: 775330
doi: 10.1056/NEJM197607082950203
G.E. Bauer, J. Baker, S.N. Hunyor et al. Side-effects of antihypertensive treatment: a placebo-controlled study. Clin Sci Mol Med Suppl 4(Dec), 341s–344s (1978)
pubmed: 282081
A.E. Fletcher, P.C. Chester, C.M. Hawkins et al. The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens 3(Apr 2), 125–130 (1989)
pubmed: 2668524
Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension, Report of medical research council working party on mild to moderate hypertension. Lancet 2(Sep 8246), 539–543 (1981)
G. Olsson, N. Rehnqvist, A. Sjögren et al. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol 5(Jun 6), 1428–1437 (1985)
pubmed: 3889100
doi: 10.1016/S0735-1097(85)80360-0
S. Wassertheil-Smoller, M.D. Blaufox, A. Oberman et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 114(Apr 8), 613–620 (1991)
pubmed: 2003706
doi: 10.7326/0003-4819-114-8-613
C.P. Broekman, S.M. Haensel, L.L. Van de Ven et al. Bisoprolol and hypertension: effects on sexual functioning in men. J Sex Marital Ther 18(4), 325–331 (1992). Winter
pubmed: 1291703
doi: 10.1080/00926239208412857
D.L. Morrissette, M.H. Skinner, B.B. Hoffman et al. Effects of antihypertensive drugs atenolol and nifedipine on sexual function in older men: a placebo-controlled, crossover study. Arch Sex Behav 22(Apr 2), 99–109 (1993)
pubmed: 8476337
doi: 10.1007/BF01542360
R. Fogari, A. Zoppi, L. Corradi et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 11(Oct 10), 1244–1247 (1998)
pubmed: 9799042
doi: 10.1016/S0895-7061(98)00139-3
R. Fogari, A. Zoppi, L. Poletti et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 14(Jan 1), 27–31 (2001)
pubmed: 11206674
doi: 10.1016/S0895-7061(00)01214-0
D. Franzen, A. Metha, N. Seifert et al. Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study. Int J Impot Res 13(Dec 6), 348–351 (2001)
pubmed: 11918251
doi: 10.1038/sj.ijir.3900787
R. Fogari, P. Preti, G. Derosa et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 58(Jun 3), 177–180 (2002)
pubmed: 12107602
doi: 10.1007/s00228-002-0456-3
B. Boydak, S. Nalbantgil, F. Fici et al. A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clin Drug Investig 25(6), 409–416 (2005)
pubmed: 17532681
doi: 10.2165/00044011-200525060-00006
E.J. Eichhorn, M.J. Domanski, H. Krause-Steinrauf et al. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344(May 22), 1659–1667 (2001)
pubmed: 11386264
F. Freytag, A. Schelling, T. Meinicke et al. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study. Clin Ther 23(Jan 1), 108–123 (2001)
pubmed: 11219471
doi: 10.1016/S0149-2918(01)80034-5
L.M. Van Bortel, C.J. Bulpitt, F. Fici, Quality of life and antihypertensive effect with nebivolol and losartan. Am J Hypertens 18(Aug 8), 1060–1066 (2005)
pubmed: 16296572
Aldemir, M. Keleş, İ, M. Karalar et al. Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft. Anatol J Cardiol 16(Feb 2), 131–136 (2016)
pubmed: 26467373
E.J. Benjamin, P. Muntner, A. Alonso et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139(Mar 10), e56–e528 (2019)
pubmed: 30700139
C.K. Chow, K.K. Teo, S. Rangarajan et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310(Sep 9), 959–968 (2013)
pubmed: 24002282
doi: 10.1001/jama.2013.184182
T.A. Farley, M.A. Dalal, F. Mostashari et al. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 38(Jun 6), 600–609 (2010)
pubmed: 20494236
doi: 10.1016/j.amepre.2010.02.016
C.I. Voils, M. Sandelowski, P. Dahm et al. Selective adherence to antihypertensive medications as a patient-driven means to preserving sexual potency. Patient Prefer Adherence 2(Feb), 201–206 (2008)
pubmed: 19920964
pmcid: 2770379
doi: 10.2147/PPA.S3796
A. Manolis, M. Doumas, C. Ferri et al. Erectile dysfunction and adherence to antihypertensive therapy: focus on β-blockers. Eur J Intern Med 81(Nov), 1–6 (2020)
pubmed: 32693940
doi: 10.1016/j.ejim.2020.07.009
T. Unger, C. Borghi, F. Charchar et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension 75(Jun 6), 1334–1357 (2020)
pubmed: 32370572
doi: 10.1161/HYPERTENSIONAHA.120.15026
P.K. Whelton, R.M. Carey, W.S. Aronow et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(Jun 6), 1269–1324 (2018)
pubmed: 29133354
doi: 10.1161/HYP.0000000000000066
Guideline for the Pharmacological Treatment of Hypertension in Adults. Geneve. World Health Organization; 2021. 2021. Available from: https://iris.who.int/bitstream/handle/10665/344424/9789240033986-eng.pdf
N. Freemantle, J. Cleland, P. Young et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. Bmj 318(Jun 7200), 1730–1737 (1999)
pubmed: 10381708
pmcid: 31101
doi: 10.1136/bmj.318.7200.1730
M.R. Bristow, beta-adrenergic receptor blockade in chronic heart failure. Circulation 101(Feb 5), 558–569 (2000)
pubmed: 10662755
doi: 10.1161/01.CIR.101.5.558
G. Rastrelli, G. Corona, F. Lotti et al. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. J Sex Med 11(Jan 1), 173–186 (2014)
pubmed: 24433560
doi: 10.1111/jsm.12342
G.T. do Vale, C.S. Ceron, N.A. Gonzaga et al. Three generations of β-blockers: history, class differences and clinical applicability. Curr Hypertens Rev 15(1), 22–31 (2019)
pubmed: 30227820
doi: 10.2174/1573402114666180918102735
C. Ferri, The role of nebivolol in the management of hypertensive patients: from pharmacological profile to treatment guidelines. Future Cardiol 17(Nov 8), 1421–1433 (2021)
pubmed: 34060323
doi: 10.2217/fca-2021-0048
A.M. Isidori, A. Aversa, A. Calogero et al. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(Dec 12), 2385–2403 (2022)
pubmed: 36018454
pmcid: 9415259
doi: 10.1007/s40618-022-01859-7
G. Corona, G. Rastrelli, L. Vignozzi et al. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs 17(Jun 2), 239–259 (2012)
pubmed: 22612692
doi: 10.1517/14728214.2012.683411
D.T. Ko, P.R. Hebert, C.S. Coffey et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288(Jul 3), 351–357 (2002)
pubmed: 12117400
doi: 10.1001/jama.288.3.351
Y. Gao, P.M. Vanhoutte, Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker. J Cardiovasc Pharmacol 59(Jan 1), 16–21 (2012)
pubmed: 21283024
doi: 10.1097/FJC.0b013e3182073e27
I.M.F. Wikananda, I. Nurcahya, P. Wijaya et al. Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis. Caspian J Intern Med 15(1), 28–37 (2024)
pubmed: 38463918
pmcid: 10921108